Combination Drug Holds Promise in Breast Cancer Treatment

Combination Drug Holds Promise in Breast Cancer Treatment

In a new research by the Perelman School of Medicine of the University of Pennsylvania, the combination of the new breast cancer drug palbociclib with paclitaxel (Taxol) was able to reduce the size of tumors in almost half of the patients who are

(Visited 3 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.